Implications for the Serogroup Incidence of Meningococcal Disease after the Introduction of the Menc Vaccine

Clarke SC Christie P Reid JA Thorn L Denham BC Edwards GFS . Meningococcal disease in Scotland 1998. SCIEH Weekly Report 1999; 33 (99/45): 286–88.

Noah N Henderson B . Surveillance of bacterial meningitis in Europe 1997/98. Public Health Laboratory Service 1998.

Chief Medical Officer. Start of the new meningococcal C conjugate vaccine immunisation programme. Department of Health, London, 18th October 1999.

Maiden MCJ Spratt BG . Meningococcal conjugate vaccines: new opportunities and new challenges. The Lancet 1999; 354: 615–16.

Maiden MCJ Bygraves JA Feil E Moreffi G Russell JE Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140–3145.

Wang J-F Caugant DA Moreffi G Koumare B Achtman M . Antigenic and epidemiological properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis 1993; 167: 1320–1329.

Swartley JS Marfin AA Edupganti S Capsule switching of Neisseria meningitidis. Proc Nati Acad Sci USA 1997; 94: 271–276.

Vogel U Claus H . Rapid serogroup switching in Neisseria meningitidis. New Engl J Med 2000; 342: 219–220.

Maiden MCJ Spratt BG . Meningococcal conjugate vaccines: new opportunities and new challenges. The Lancet 1999; 354: 615–16.

Rosenstein NE Perkins BA Stephens DS The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 1999; 180: 1894–1901.